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Abstract
A carbapenem-resistant Klebsiella pneumoniae was isolated from a
blood-culture of an inpatient from Libya, hospitalized in the
intensive-care unit of Negrar Hospital, Italy. The clinical isolate
carried the following b-lactamase genes, blaTEM-1, blaSHV-11,
blaOXA-1, blaCTX-M-15 and blaOXA-48, respectively. The blaOXA-48
gene was inserted in the Tn1999.2 transposon type, carried on a
conjugative, 60-kilobase plasmid, that presented an L/M backbone,
hosted by a multidrug-resistant ST 101 K. pneumoniae strain. Our
report highlights the international transfer of blaOXA-48 gene and
the importance of screening measures of multidrug-resistant
Enterobacteriaceae.
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The blaOXA-48 gene was ﬁrst identiﬁed in a Klebsiella pneumo-
niae isolate from Turkey [1]. Since then, OXA-48-producing
strains have been reported mainly from North African
countries, the Middle East, Turkey and India, although
occurrence of such strains in several European countries is
now well documented [2,3]. Although, OXA-type b-lactamases
are dominantly found in Acinetobacter species, the blaOXA-48
gene has only been detected in Enterobacteriaceae isolates [3];
it is endowed with a narrow hydrolysing spectrum including
penicillins and carbapenems, but not extended-spectrum
cephalosporins and monobactams [3]. A 60-kilobase plasmid
is the main genetic vehicle of the blaOXA-48 gene in many
Enterobacteriaceae species [4]. This self-conjugative plasmid
possesses an IncL/M type backbone with no other antibiotic-
resistance genes [3]. The blaOXA-48 gene is settled in a
composite transposon, namely Tn1999, or in the second
variant Tn1999.2 or in the latest one, Tn1999.3 [5,6]. The aim
of our study was to characterize the genetic background and
plasmid proﬁle of an OXA-48-producing K. pneumoniae clinical
isolate recovered from a patient originating from Libya.
A carbapenem-resistant K. pneumoniae strain, 2605, was
isolated in September 2011 from a blood culture of a 33-year-
old man, 1 day after his admission to the intensive-care unit of
the Sacro Cuore—Don Calabria Hospital in Negrar, Italy. The
patient was a refugee from Libya, where he had been injured by
a bomb explosion and had reported multiple traumas such as
vertebral fractures and ureteral lesions. He was transferred
from a Tripoli hospital directly to the urology unit of the Sacro
Cuore Hospital, where he stayed for 9 days before being
moved to intensive care.
Antimicrobial susceptibility testing was performed by broth
microdilution, and the MICs of carbapenems, cephalosporins,
aztreonam, ﬂuoroquinolones, aminoglycosides and tigecycline
were interpreted according to the latest EUCAST documents
(http://www.eucast.org/clinical_breakpoints/ version 3.1).
The strain proved to be resistant to all broad-spectrum
cephalosporins and to ﬂuoroquinolones, and susceptible to
tigecycline. Imipenem had an MIC of 1 mg/L, a value still in the
lower susceptibility range, the MIC for meropenem was
evaluated as intermediate susceptible and for ertapenem as
resistant category (Table 1).
The presence of b-lactamase genes encoding extended
spectrum b-lactamase, AmpC and carbapenemases was
checked by PCR using a set of screening primers [7].
TABLE 1. Minimal inhibitory concentrations (mg/L) of 2605
Klebsiella pneumoniae clinical isolate, its trans-conjugant (Tc)
and J53 Escherichia coli
2605
K. pneumoniae
Tc/2605
E. coli
J53
E. coli
Cefotaxime >128 0.06 0.06
Ceftazidime >128 0.06 0.03
Cefepime >128 0.03 0.03
Aztreonam >128 0.06 0.03
Imipenem 1 0.25 0.03
Meropenem 8 0.25 0.03
Ertapenem 64 2 0.03
Ciproﬂoxacin 64 0.03 0.03
Levoﬂoxacin 8 0.03 0.03
Gentamicin 0.5 0.125 0.06
Tigecycline 0.25 0.25 0.25
Colistin 32 0.25 0.25
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After PCR and sequencing of the amplicons (MWG Euroﬁns
Operon, Ebersberg, Germany), the strain was shown to
harbour the multiple b-lactamase genes, namely blaTEM-1,
blaSHV-11, blaOXA-1, blaCTX-M-15 and blaOXA-48.
The broth mating assay, in which J53 azide-resistant
Escherichia coli was used as the recipient strain, provided
trans-conjugant cells harvested from Luria–Bertani agar plates
supplemented with 0.5 mg/L ertapenem and 100 mg/L sodium
azide. The trans-conjugant carried only the blaOXA-48 gene as
the carbapenem-resistant determinant.
The PCR-based replicon typing [8,9] showed that the
clinical isolate was positive for the IncR and colE incompat-
ibility groups, and was not detected in the L/M plasmid type,
which is usually reported to harbour OXA-48 [3]. The trans-
conjugant was negative for the IncR and colE incompatibility
groups, suggesting that the plasmid transferring the blaOXA-48
gene may be untypeable.
After plasmid extraction (Qiagen, Hilden, Germany) from
both the clinical isolate and its trans-conjugant, Southern
blotting was performed with a blaOXA-48 digoxigenin-labelled
probe and revealed blaOXA-48 to be located on a high-
molecular-weight plasmid. The size of this plasmid was
clariﬁed by pulsed-ﬁeld gel electrophoresis performed after
S1 digestion [10], and showed the both the clinical isolate and
its trans-conjugant harbour a plasmid sized around 60 kilo-
bases.
To further classify this plasmid we ampliﬁed the repA, traU
and parA genes responsible for the conserved region of the
IncL/M plasmid backbone by using the formerly published
primers [3]. The nucleic acid sequence we found matched the
plasmid sequence of JN626286 with high similarity, suggesting
that the plasmid carrying the blaOXA-48 gene under study is
characterized by an IncL/M-like backbone [3]. According to
Glupczynski et al. [11], in our study no association between
blaOXA-48 and the repP gene was found by using the primers
designed by Carr€er et al. [12] to detect repP, which they found
located upstream of Tn1999.
The genetic surrounding of the blaOXA-48 gene was mapped
by PCR using primer pairs speciﬁc for the insertion sequence
IS1999 [5]. The blaOXA-48 gene was found in the Tn1999.2
variant.
Strain genotyping was performed by multi-locus sequence
typing to determine the sequence type (ST) of the isolate.
Allelic numbers were obtained on the basis of sequences of
seven housekeeping genes at the http://www.pasteur.fr/recher-
che/genopole/PF8/mlst/Kpneumoniae. Multi-locus sequence
typing identiﬁed the K. pneumoniae 2605 as an ST 101 strain,
i.e. an international clone isolated in Tunisia [13] and
responsible for a recent outbreak in Spain [14].
Carbapenem resistance does not respect geographic bor-
ders, as witnessed by the widespread of the KPC, VIM and
NDM enzymes [2]. Since the patient was transported directly
from Libya the most likely origin of this OXA-48-producing
isolate was this North African country, in accordance with
earlier reports describing transport from Libya to Slovenia
[15] and from Egypt to Italy [6]. In our study we conﬁrmed
that the blaOXA-48 gene was inserted in the Tn1999.2
transposon type, carried on a conjugative, 60 kb with IncL/
M-like backbone plasmid hosted by a multidrug-resistant
ST 101 K. pneumoniae strain.
In contrast to other carbapenemases, for which in vitro
inhibitory assays can be applied, no reliable phenotypic test can
detect class D b-lactamase production including OXA-48.
Additionally, its peculiar hydrolytic spectrum, sparing
extended-spectrum cephalosporins, makes OXA-48 a hidden
carbapenemase, especially when the clinical isolate does not
co-express extended spectrum b-lactamases. The number of
reports describing OXA-48-producing clinical isolates co-
hosting extended spectrum b-lactamases has increased [4,11–
14,16], highlighting the fact that the detection of extended
spectrum b-lactamases can raise suspicion for the presence of
the blaOXA-48 gene in Enterobacteriaceae. As OXA-48 is an
extensively spreading carbapenemase, collecting the precise
epidemiological data is crucial to elucidate the true prevalence.
Following the isolation of this carbapenem-resistant strain,
the microbiology laboratory recognized the potential risk of an
outbreak and performed active screening for all the intensive-
care unit patients by rectal swab to check the presence of
other carbapenem-resistant strains. For all other units an
automatic alert on carbapenem MIC was adopted. Using
appropriate screening and increasing surveillance in the
hospital could indeed prevent a possible outbreak.
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